Kannan Kashi Vishwanath
Corporate Officer/Principal en Indo-American Chamber of Commerce & Industry .
Perfil
Dr. Kannan Kashi Vishwanath is Vice Chairman & Managing Director at Dr. Datsons Labs Ltd.
and a Member at Indo-American Chamber of Commerce & Industry.
He is on the Board of Directors at Dr. Datsons Labs Ltd.
and Finaventure Capital Ltd.
He received his undergraduate degree from the University of Pune, an MBA from Hamilton College (New York), and a doctorate degree from The International University.
Cargos activos de Kannan Kashi Vishwanath
| Empresas | Cargo | Inicio |
|---|---|---|
| Indo-American Chamber of Commerce & Industry | Corporate Officer/Principal | 17/06/2011 |
Antiguos cargos conocidos de Kannan Kashi Vishwanath.
| Empresas | Cargo | Fin |
|---|---|---|
| FINAVENTURE CAPITAL LTD | Director Ejecutivo | 14/02/2015 |
| DR DATSONS LABS LTD | Fundador | 21/08/2014 |
Formación de Kannan Kashi Vishwanath.
| Hamilton College (New York) | Masters Business Admin |
| University of Pune | Undergraduate Degree |
| The International University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
| Indo-American Chamber of Commerce & Industry | |
Finaventure Capital Ltd.
 Finaventure Capital Ltd. Investment ManagersFinance Finaventure Capital Ltd. is an investment company, which engages in the business of investments in listed and unlisted companies. The company was founded on January 19, 1985 and is headquartered in Mumbai, India. | Finance |
Dr.Datsons Labs Ltd.
 Dr.Datsons Labs Ltd. Pharmaceuticals: MajorHealth Technology Dr. Datsons Labs Ltd. engages in the manufacture, and market of contract research and manufacturing services (CRAMS), and active pharmaceutical ingredients (API). It operates through the following segments: Active Pharmaceutical Ingredients (API), Formulation, and Trading. The API segment manufactures second generation anti-malaria APIs like quinine and salts as well as third generation anti-malarial products like Artemisinin-based salts. The company was founded by Kannan Kashi Vishwanathan on January 3, 2006 and is headquartered in Mumbai, India. | Health Technology |
- Bolsa de valores
- Insiders
- Kannan Kashi Vishwanath
